Anderson Miyoshi Selected Research

Lymphadenitis (Adenitis)

1/2016	The Corynebacterium pseudotuberculosis genome contains two formamidopyrimidine-DNA glycosylase enzymes, only one of which recognizes and excises 8-oxoguanine lesion.
12/2014	Corynebacterium pseudotuberculosis cp09 mutant and cp40 recombinant protein partially protect mice against caseous lymphadenitis.
11/2014	Serological proteome analysis of Corynebacterium pseudotuberculosis isolated from different hosts reveals novel candidates for prophylactics to control caseous lymphadenitis.
3/2013	Conserved host-pathogen PPIs. Globally conserved inter-species bacterial PPIs based conserved host-pathogen interactome derived novel target in C. pseudotuberculosis, C. diphtheriae, M. tuberculosis, C. ulcerans, Y. pestis, and E. coli targeted by Piper betel compounds.
5/2012	Structure modeling of a metalloendopeptidase from Corynebacterium pseudotuberculosis.
3/2011	Corynebacterium pseudotuberculosis secreted antigen-induced specific gamma-interferon production by peripheral blood leukocytes: potential diagnostic marker for caseous lymphadenitis in sheep and goats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anderson Miyoshi Research Topics

Disease

10	Colitis 11/2020 - 01/2011
9	Inflammation (Inflammations) 01/2021 - 01/2008
8	Infections 12/2014 - 03/2006
6	Lymphadenitis (Adenitis) 01/2016 - 03/2011
3	Tuberculosis (Tuberculoses) 01/2021 - 03/2012
3	Crohn Disease (Crohn's Disease) 01/2020 - 02/2011
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 01/2011
2	Mastitis 10/2014 - 06/2012
2	Schistosomiasis (Bilharziasis) 12/2013 - 08/2005
2	Neoplasms (Cancer) 01/2013 - 02/2011
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021
1	Fibrosis (Cirrhosis) 11/2020
1	Arthritis (Polyarthritis) 01/2020
1	Weight Loss (Weight Reduction) 11/2014
1	Hematologic Neoplasms (Hematological Malignancy) 02/2014
1	Shock 01/2014
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 02/2013
1	Carcinogenesis 01/2013
1	Lung Neoplasms (Lung Cancer) 01/2013
1	Meningoencephalitis 01/2013
1	Vibrio Infections 01/2013
1	Pneumonia (Pneumonitis) 10/2010
1	Schistosomiasis mansoni 12/2008
1	Colonic Neoplasms (Colon Cancer) 01/2008
1	Colorectal Neoplasms (Colorectal Cancer) 01/2008
1	Brucellosis (Malta Fever) 01/2003

Drug/Important Bio-Agent (IBA)

8	VaccinesIBA 01/2021 - 01/2003
7	Interleukin-10 (Interleukin 10)IBA 01/2021 - 01/2011
7	Proteins (Proteins, Gene)FDA Link 11/2014 - 07/2011
6	AntigensIBA 01/2021 - 01/2003
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2012
4	Dextrans (Dextran)FDA Link 08/2014 - 04/2012
3	Interleukin-12 (IL 12)IBA 01/2021 - 01/2014
3	CytokinesIBA 01/2020 - 01/2011
2	Interleukin-4 (Interleukin 4)IBA 01/2021 - 08/2016
2	Sulfonic AcidsIBA 11/2020 - 08/2014
2	Biological ProductsIBA 01/2019 - 03/2013
2	Interleukin-6 (Interleukin 6)IBA 08/2016 - 01/2014
2	Complementary DNA (cDNA)IBA 06/2015 - 11/2014
2	bacterial fibronectin-binding proteinsIBA 02/2015 - 08/2014
2	DNA VaccinesIBA 02/2015 - 12/2008
2	AcidsIBA 11/2014 - 01/2014
2	SodiumIBA 08/2014 - 01/2014
2	Virulence Factors (Pathogenicity Factors)IBA 03/2014 - 04/2011
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2014 - 04/2012
2	CatalaseIBA 02/2011 - 01/2008
2	Trinitrobenzenesulfonic AcidIBA 02/2011 - 01/2011
1	Insulin (Novolin)FDA Link 01/2021
1	sym-trinitrobenzeneIBA 11/2020
1	methylated bovine serum albumin (MBSA)IBA 01/2020
1	Rheumatoid FactorIBA 01/2020
1	CollagenIBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	AntibodiesIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Drinking WaterIBA 01/2019
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2017
1	Recombinant ProteinsIBA 12/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2014
1	ProteomeIBA 11/2014
1	InterleukinsIBA 11/2014
1	Immunoglobulin A (IgA)IBA 08/2014
1	IronIBA 03/2014
1	GlycopeptidesIBA 12/2013
1	Pharmaceutical PreparationsIBA 01/2013
1	Transfer RNA (tRNA)IBA 01/2013
1	Transcription Factors (Transcription Factor)IBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	Generic DrugsIBA 01/2013
1	MicroRNAs (MicroRNA)IBA 01/2013
1	EnzymesIBA 05/2012
1	Sigma FactorIBA 01/2012
1	Interferon-gamma (Interferon, gamma)IBA 03/2011
1	Superoxide DismutaseIBA 02/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2011
1	Xylose (D-Xylose)FDA Link 01/2011
1	Diphtheria ToxinIBA 10/2010
1	Phospholipase DIBA 10/2010
1	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 01/2008
1	Dimenhydrinate (DMH)FDA LinkGeneric 01/2008
1	Fatty Acid-Binding ProteinsIBA 08/2005
1	Salmonella VaccinesIBA 08/2005
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2003

Therapy/Procedure

4	Oral Administration 11/2020 - 08/2005
4	Therapeutics 01/2019 - 11/2014
1	Stem Cell Transplantation 02/2014